|
"jia horng kao"的相關文件
顯示項目 986-1010 / 1180 (共48頁)
<< < 35 36 37 38 39 40 41 42 43 44 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
|
Liu, Chun-Jen;Chen, Pei-Jer;Lai, Ming-Yang;Liu, Chen-Hua;Chen, Chi-Ling;Kao, Jia-Horng;Chen, Ding-Shinn; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHEN, PEI-JER; LAI, MING-YANG; LIU, CHEN-HUA; CHEN, CHI-LING; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:23:47Z |
Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients
|
Chu, Cheng-Hsin;Yang, An-Ming;Kao, Jia- Horng;Liu, Chia-Yuan;Chang, Wen-Hsiung;Yang, Wei-Shiung; WEI-SHIUNG YANG; JIA-HORNG KAO; CHU, CHENG-HSIN; YANG, AN-MING; KAO, JIA- HORNG; LIU, CHIA-YUAN; CHANG, WEN-HSIUNG; YANG, WEI-SHIUNG |
| 臺大學術典藏 |
2018-09-10T07:06:33Z |
Hepatitis C virus infection in Taiwan
|
Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update (Hepatology International 10.1007/s12072-008-9080-3)
|
Liaw, Y.-F.;Leung, N.;Kao, J.-H.;Teerha, P.;Gane, E.;Han, K.-H.;Guan, R.;Lau, G.K.K.;Locarnini, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Genetic variability of hepatitis B virus and response to antiviral therapy
|
Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B
|
Lin, C.-L.;Kao, J.-H.; Lin, CL; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B
|
Huang, Y.-W.;Lin, C.-L.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Combination of Hepatitis B Viral Factors and Advanced Liver Disease in HBeAg-Negative Patients: The More, the Worse?
|
Lin, Chih–Lin; Branch, Ren–Ai; Kao, Jia–Horng; JIA-HORNG KAO; Lin, Chih–Lin; Branch, Ren–Ai; Kao, Jia–Horng |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Diagnosis of hepatitis B virus infection through serological and virological markers
|
Kao, J.-H.; JIA-HORNG KAO; Kao, JH |
| 臺大學術典藏 |
2018-09-10T07:06:29Z |
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
|
Liaw, Yun-Fan; Leung, Nancy; Kao, Jia-Horng; Piratvisuth, Teerha; Gane, Edward; Han, Kwang-Hyub; Guan, Richard; Lau, George K. K.; Locarnini, Stephen; JIA-HORNG KAO; Liaw, Yun-Fan; Leung, Nancy; Kao, Jia-Horng; Piratvisuth, Teerha; Gane, Edward; Han, Kwang-Hyub; Guan, Richard; Lau, George K. K.; Locarnini, Stephen |
| 臺大學術典藏 |
2018-09-10T07:06:29Z |
Association of Insulin Resistance with Alanine Aminotransferase Activity in Patients with Nonalcoholic Fatty Liver Disease
|
Wang, C.-C.;Wu, W.-W.;Hsu, C.-S.;Wang, P.-C.;Lin, H.H.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Universal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone
|
Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone
|
Kao, J.-H.; Lai, M.-Y.; Chen, W.; Chen, P.-J.; Chen, D.-S.; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:12Z |
Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections
|
Kao, J.-H.; Chen, R.-J.; Lai, M.-Y.; Chen, W.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:10Z |
Critical analysis of the immune tolerance phase of chronic HBV infection: Natural history and diagnosis
|
Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
顯示項目 986-1010 / 1180 (共48頁)
<< < 35 36 37 38 39 40 41 42 43 44 > >>
每頁顯示[10|25|50]項目
|
